Search This Blog

Thursday, February 27, 2020

Denali Therapeutics EPS beats by $0.05, misses on revenue

Denali Therapeutics (NASDAQ:DNLI): Q4 GAAP EPS of -$0.56 beats by $0.05.
Revenue of $4.67M (-96.3% Y/Y) misses by $1.45M.
Press Release
https://seekingalpha.com/news/3546795-denali-therapeutics-eps-beats-0_05-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)